4
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prevalence of diabetes and determinants: evidence from a minority region in People’s Republic of China

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          This study aimed to examine the prevalence of diabetes mellitus and other categories of glucose intolerance (impaired glucose tolerance and impaired fasting glucose) and explore the risk factors in an ethnic minority region, Guangxi Zhuang Autonomous Region, People’s Republic of China.

          Methods

          A population-based study enrolled 53,270 residents older than 5 years in Guangxi, People’s Republic of China. The prevalence of diabetes was calculated using the 1999 World Health Organization (WHO) oral glucose tolerance test diagnostic criteria.

          Results

          Among 53,270 individuals, the prevalence of diabetes, impaired glucose tolerance, and impaired fasting glucose was 5.96%, 7.36%, and 2.62%, respectively. Of the 3,173 individuals with diabetes mellitus, 696 (21.94%) were found to have a history of diabetes and 2,477 (78.06%) were newly diagnosed. A lower prevalence was found in Zhuang ethnic minority people compared with the majority of Han people. The prevalence was significantly associated with age, body mass index, waist-to-hip ratio, dyslipidemia, medical history of hypertension, and family history of diabetes.

          Conclusion

          Guangxi shows a rapidly rising prevalence of diabetes. Weight control and blood lipid control are important to decrease the rapidly increasing prevalence of diabetes in Guangxi, an ethnic minority region.

          Related collections

          Most cited references 18

          • Record: found
          • Abstract: found
          • Article: not found

          Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

          The goal of this study was to estimate the prevalence of diabetes and the number of people of all ages with diabetes for years 2000 and 2030. Data on diabetes prevalence by age and sex from a limited number of countries were extrapolated to all 191 World Health Organization member states and applied to United Nations' population estimates for 2000 and 2030. Urban and rural populations were considered separately for developing countries. The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030. The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men. The urban population in developing countries is projected to double between 2000 and 2030. The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age. These findings indicate that the "diabetes epidemic" will continue even if levels of obesity remain constant. Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Computational Many-Particle Physics

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease.

               J VAGUE (2015)
                Bookmark

                Author and article information

                Journal
                Ther Clin Risk Manag
                Ther Clin Risk Manag
                Therapeutics and Clinical Risk Management
                Therapeutics and Clinical Risk Management
                Dove Medical Press
                1176-6336
                1178-203X
                2016
                14 March 2016
                : 12
                : 427-433
                Affiliations
                [1 ]Department of Endocrinology, First Affiliated Hospital of Guangxi Medical University, People’s Republic of China
                [2 ]School for International Education, Guangxi Medical University, Nanning, People’s Republic of China
                [3 ]Department of Public Health, Guangxi Medical University, Nanning, People’s Republic of China
                [4 ]The Second People’s Hospital of Qinzhou, Qinzhou, People’s Republic of China
                [5 ]Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, People’s Republic of China
                [6 ]Nandan County People’s Hospital, Nandan, People’s Republic of China
                [7 ]Tumor Hospital of Guangxi Zhuang Autonomous Region, Nanning, People’s Republic of China
                [8 ]Hezhou City People’s Hospital, Hezhou, People’s Republic of China
                [9 ]Long’an County People’s Hospital, Nanning, Guangxi, People’s Republic of China
                Author notes
                Correspondence: Qingyun Chen, Department of Endocrinology, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi 530021, People’s Republic of China, Email qychen8688@ 123456126.com
                Article
                tcrm-12-427
                10.2147/TCRM.S90220
                4798220
                27042084
                © 2016 Chen et al. This work is published and licensed by Dove Medical Press Limited

                The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

                Categories
                Original Research

                Medicine

                ethnic minority, prevalence, factors, diabetes mellitus, diagnosis, ogtt

                Comments

                Comment on this article